Dong A University Hospital

Seogu, Busan Gwangyeogsi 49201

2 studies enrolling now · 5 studies all time

What they study most

Advanced/Metastatic Solid Tumors, CLL, Chronic Lymphocytic Leukemia, HR+/HER2- Breast Cancer, Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC), Marginal Zone Lymphoma, Nonsmall Cell Lung Cancer, Stage IIIB, Nonsmall Cell Lung Cancer, Stage IV, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer — Completed